Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor for dopamine neurons that has been proposed for use in the treatment of Parkinson's disease (PD). Previous studies using viral vectors to deliver GDNF in rodent models of PD have entailed administering the virus either prior to or immediately after neurotoxin-induced lesions, when the nigrostriatal pathway is largely intact, a paradigm that does not accurately reflect the clinical situation encountered with Parkinson's patients. In this study, recombinant adeno-associated virus carrying the gene encoding GDNF (rAAV-GDNF) was administered to animals bearing a maximal lesion in the nigrostriatal system, more closely resembling fully developed PD. Rats were treated with 6-hydroxydopamine into the medial forebrain bundle and assessed by apomorphine-induced rotational behavior for 5 weeks prior to virus administration. Within 4 weeks of a single intrastriatal injection of rAAV-GDNF, unilaterally lesioned animals exhibited significant behavioral recovery, which correlated with increased expression of dopaminergic markers in the substantia nigra, the medial forebrain bundle, and the striatum. Our findings demonstrate that rAAV-GDNF is capable of rescuing adult dopaminergic neurons from near complete phenotypic loss following a neurotoxic lesion, effectively restoring a functional dopaminergic pathway and diminishing motoric deficits. These data provide further support for the therapeutic potential of rAAV-GDNF-based gene therapy in the treatment of PD.
INTRODUCTION
aging process have all been suggested as factors that may contribute to the etiology of PD (8, 19, 66) , but the cause(s) is still unknown. Parkinson's disease (PD) is a neurodegenerative disease that involves an extensive loss of dopamine in the Recently, studies utilizing labeled tracers have revealed that damaged dopamine neurons, both in human PD and striatum of affected individuals (20, 50, 57, 63) . Symptoms of PD include tremor, rigidity, bradykinesia, stooped in animal models of the disease, may still retain some function. It has been proposed that these damaged dopa-posture, and general akinesia (54, 55, 64, 65) . These clinical signs appear to relate to a loss of dopaminergic neu-mine neurons have lost their dopaminergic phenotype and that they may be salvaged if appropriate therapeutic mea-ronal phenotype primarily within the substantia nigra pars compacta located in the ventral mesencephalon sures are applied to the central nervous system (7, 10, 14, 16, 30, 41, 51, 52, 61, 69, 72) . A particularly promising growth (36, 62) , which is associated with a >80% decrease in the levels of dopamine in the striatum (50, 57) . Genetic factor for damaged dopamine neurons is glial cell linederived neurotrophic factor (GDNF). GDNF is known to abnormalities, environmental toxins, and the normal protect dopamine neurons in vitro (48) and it promotes MATERIALS AND METHODS recovery of the injured nigrostriatal dopamine system Animals and improves motor function in rodent and nonhuman Male Fischer 344 rats (170-240 g, Harlan Spragueprimate models of PD (30, 43) . Injections of GDNF pro-Dawley, Indianapolis, IN) were used for all studies and tein itself have been found to provide protection against were housed in our Animal Resource Center with a 12-h neurotoxin-induced lesions in rodents and nonhuman light/dark cycle. Food and water were available ad libiprimates (6, 7, 14, (24) (25) (26) (27) 41, 42, 49, 51, 52, 61, 67, 70, 72) . Curtum. All animal procedures were carried out in accorrently, a new approach to PD therapy lies in the use of dance with the Declaration of Helsinki and according to gene therapy to deliver neurotrophic factors to prevent the Guide for the Care and Use of Laboratory Animals cell death and to promote dopamine neuron function (1, as adopted and promulgated by the National Institutes 4, 8, 14, 15, 43, 51, 52, 72) .
of Health, and were approved by the local animal care There are several possible viral vectors to use to deand use committee. liver trophic factors such as GDNF. Adenovirus and herpes simplex viral vectors have been shown to efficiently 6-OHDA-Induced Lesions transduce foreign genes into neurons (9, 18, 46, 58) , but Rats were anesthetized with chloral hydrate (400 mg/ both are cytotoxic to the recipient cells and induce imkg in 0.9% NaCl, IP) and placed in a stereotaxic frame mune responses against the transduced cells. Lentiviwith the incisor bar set at −2.3 mm. Unilateral injections ruses, on the other hand, can infect nondividing cells, of 6-OHDA into the right medial forebrain bundle were but these are vectors based on the human immunodefiperformed (coordinates −4.4 mm AP, −1.3 mm ML, and ciency virus (HIV) and could potentially transduce non-−7.8 mm DV from the dural surface). The fresh, preproliferating cells, including neurons in vivo (5, 39, 56) . pared daily 6-OHDA solution (9 µg/4 µl saline contain-Because HIV prevents cellular mitosis, development of ing 0.02% ascorbate) was injected using a 10-µl SGE packaging cell lines that can enable vector generation syringe fitted with a dome-tipped needle at a rate of 1 has been hampered. Also, safety concerns arise with the µl per minute over 4 min. The needle was kept in place lentivirus vector because it is an HIV-based vector, and an additional minute prior to retraction. use of the vector in clinical trials could pose a potential Apomorphine-Induced Rotational Behavior danger to patients (39). However, great success has been achieved in monkeys with the use of a modified lentivi-Beginning 1 week after 6-OHDA-induced lesions, rus for GDNF (43) . rats were tested once weekly for apomorphine-induced Another promising gene delivery vehicle for neurons rotational behavior to assess the extent of dopamine is the adeno-associated virus (AAV)-based vector. AAV depletion in the striatum ipsilateral to the lesion. The is a nonpathogenic DNA virus that contains several biorotations were quantified weekly using an automated rological properties that make this viral vector potentially tometer system (37) . Rats were permitted to acclimate useful as a clinical gene therapy vector: 1) lack of assoto the rotometer bowls and baseline recordings were ciation with disease, 2) the ability to latently infect a made for 10 min prior to receiving a single SC injection high fraction of exposed cells, 3) a minimal number of of low-dose apomorphine (0.05 mg/kg in 0.9% NaCl viral antigens to induce a host immune response, 4) the containing 0.02% ascorbate). Only complete rotations possible ability to latently infect nondividing cells, 5) were counted. Rats were required to respond to apomorthe possible advantage of site-specific integration, and phine treatment with a minimum of 300 contralateral 6) the ability to latently infect a broad range of human turns per hour (averaged across the final three tests) in cells (3, 45, 47, 53, 68) . order to be included in the study. We have shown that In this study, we have used a newly developed rAAV this criteria predicts a >99% depletion of striatal dopafor GDNF (rAAV-GDNF) in order to try and restore mine (36) . Measures of apomorphine-induced rotational function to severely damaged dopamine neurons. The behavior were quantified in the same manner beginning virus was directly injected into the substantia nigra of 1 week following intracranial injections of rAAV-GDNF rats that were unilaterally lesioned with 6-hydroxydopaor control virus and were continued every week for 4 mine (6-OHDA) several weeks before treatment, to simweeks. ulate an advanced stage of neurodegeneration usually DNA Constructs seen in the later stages of PD. In contrast, previous studies have primarily focused on neuroprotection by GDNF The plasmid vectors used to direct rAAV production were all derived from psub201, a biologically active rather than neuronal repair (10, 26, 40, 41, 43) . Following administration of the virus, behavioral and morphologi-DNA clone of AAV (serotype 2) (60). The protypical construct, carrying the recombinant AAV genome, the AAV cal effects of the rAAV-GDNF were studied in this animal model of PD.
rep and cap genes, the ampicillin resistance gene for selection in E. coli, and the neomycin resistance gene and titer determined by a TCID50 assay on 293 cells (28). Our strategy for the generation of stable rAAV pro-for selection in mammalian cells, is described in detail in Clark et al. (13) .
ducer cell lines was as previously described (14) . Briefly, subconfluent HeLa cells were transfected with the For these studies, either of two different transgenes was inserted into a multiple cloning site engineered be-rAAV/rep-cap plasmid using Lipofectamine (Life Technologies, Inc.) and selected for growth in the presence tween the two terminal ITRs of AAV in place of the rep and cap genes. Both of the transgene inserts were driven of 700 µg/ml G418. Drug-resistant colonies were picked and screened for rAAV production by a passage assay, by the major immediate-early promoter from human cytomegalovirus (CMV-MIE), including the intron A seg-scoring for transgene expression in infected HeLa cells. Positive isolates were subcloned and rescreened for the ment (11), and were flanked on the 3′ end by the polyadenylation/termination signal (pA) derived from the highest virus producers. The final rAAV producer cell lines were maintained in DMEM supplemented with bovine growth hormone gene ( Fig. 1) . One of the transgenes consisted of a variant of the gene for the green 10% FBS, 1% penicillin and streptomycin, and 700 µg/ ml G418 and were carried for no more than 30 passages. fluorescent protein (GFP) from the jellyfish Aequorea victoria (cDNA obtained from B. Seed and E. Park at
The presence of any wild-type-like AAV in the rAAV vector stocks was assessed as previously described (12) . Harvard/MGH), which carries a Ser65Thr mutation as well as over 190 silent base changes designed to en-Contamination with adenovirus helper was assayed by passing 1% of the purified rAAV stock onto 293 cells hance translational efficiency by conforming to human codon preferences (32) . The second rAAV construct car-and scoring for adenovirus CPE after 7 days. ried the cDNA encoding human glial cell line-derived Cell Lysate Preparation for Column Chromatography neurotrophic factor precursor (prepro-GDNF), which had been amplified by PCR using a human substantia
The rAAV producer cell lines were amplified stepwise: cells were seeded initially into 75-cm 2 T-flasks, nigra cDNA library (Clontech Laboratories, Inc.) as a template. The 5′ PCR primer incorporated an optimized then expanded to Triple-layer flasks (Nunc), and finally inoculated into Cell Factories TM (10-layer version, Nunc). translational start site ( Fig. 1) .
Upon reaching 70% confluency, half of the media from Cells and Viruses the Cell Factories was removed and replaced with fresh HeLa and HEK293 cells were obtained from the DMEM/2% FBS supplemented with 10 mM HEPES, 25 American Type Culture Collection (Rockville, MD). mM glucose, 2× minimal essential amino acids, and ade-HeLa cells were maintained in DMEM (Celltech) supnovirus (Ad5) at a final multiplicity of infection of 5. plemented with 10% fetal bovine serum (FBS) and peni-
The Cell Factories were then shifted down to 32°C for cillin/streptomycin; 293 cells were grown in EMEM the duration of the adenovirus infectious cycle. At maxi-(Celltech) supplemented with 10% FBS and penicillin/ mum adenoviral cytopathic effect (48 h), cells were colstreptomycin. Wild-type adenovirus type 5 was purified lected and pelleted at 2000 × g for 15 min at 4°C. The from infected HeLa cells by CsCl step and isopycnic cell pellet was resuspended in 20 mM Tris-HCl, pH 8.0, gradient centrifugations according to standard protocols 150 mM NaCl at a final cell density of 5 × 10 6 cells/ml. Sodium deoxycholate was added with mixing to a final concentration of 0.5% and incubated for 30 min at 37°C. Lysate viscosity was reduced by the addition of 50 U/ ml of Benzonase (American International Chemical) and subsequent incubation at room temperature for 20 min with occasional mixing. Cellular debris was then removed by centrifugation at 3000 × g for 15 min at 4°C. The clarified lysate was heated to 56°C for 45 min to tions (typically 2 to 3 fractions) were pooled and con-centrated using Centricon-100, reequilibrated into 20 mounted on glass slides, coverslipped, and analyzed using a Nikon Eclipse 600 light microscope. mM Tris-HCl, pH 8.0, 1 mM MgCl 2 , 150 mM NaCl, 5% glycerol, and then stored in aliquots at −80°C.
Image Analysis of GDNF and TH Immunohistochemical Staining Quantification of rAAV Particles
Immunohistochemical staining intensity of TH-posi-DNase-resistant particle (DRP) values were detertive neuronal fibers in discrete brain regions was determined for highly purified rAAV viral stocks by two mined by use of NIH Image software (written by Waine methods. The first method was a standard DNase diges-Rasband). Image is written using Think Pascal from Sytion/dot blot protocol performed as previously described mantec Corporation  , and the complete source code is (12) . The second PCR-based method employed the PE freely available. Image can be used to measure area, av-Applied Biosystems Prism 7700 sequence detector syserage gray value, as well as path lengths and angles of tem as detailed in Clark et al. (13) . cellular components. Spatial calibration is supported to Viral Injections provide real-world area and length measurements. A density calibration was performed against an optical After the animals were tested for apomorphine-induced density calibration curve that takes into account and subrotational behavior following the 6-OHDA-induced letracts the background from each section that is measion, animals exhibiting ≥300 turns per hour were ransured. The gray scale value is within the range of 0 to domly divided into two groups receiving either control 256, where 0 represents white and 256 black. Images viral vector (rAAV-GFP) or the GDNF viral vector were captured with a Cohu video camera (4990 series) (rAAV-GDNF). The injections were performed under coupled to a Nikon Optiphot microscope (20× objective) chloral hydrate anesthesia (400 mg/kg) by stereotaxic connected to a Macintosh Quadra 840 AV computer. surgical techniques. Five microliters of either the rAAV-Mean staining intensities of TH-positive fibers in the GFP or rAAV-GDNF was injected into right substantia striatum and medial forebrain bundle were thus obtained nigra at a rate of 0.25 µl/min using the following coordiand subtracted from background staining. The staining nates: incisor bar −2.3 mm, AP −5.6 mm, ML −2.0 mm, density subtracted from background was evaluated on and DV −7.0 mm from bregma (59) . Following the in-4-6 sections per brain that were separated by at least jection, the needle was left in the brain for 5 min before 300 µm. The first section in the striatum and the medial being removed.
forebrain bundle was randomly picked and systematic Histology and Immunohistochemistry random sampling was subsequently employed (every 10th section was used for image analysis). The sections were At the end of the experiment, animals were deeply evaluated blindly by two independent investigators. anesthetized with chloral hydrate (600 mg/kg) and per-In order to obtain an estimate of GDNF and THfused through the aorta with 0.9% saline followed by immunoreactive cells, we also used NIH Image to per-4% paraformaldehyde. The brains were rapidly removed form cell counts between the treatment groups. It is imfrom the skull, postfixed with 4% paraformaldehyde, portant to note that the experiments performed here were and transferred to 30% sucrose in phosphate-buffered not suitable for classical unbiased stereology measuresaline (PBS) the next day. Sections (40 µm) were obments. In general, a minimum number of 100-200 counts tained from the striatal and nigral regions of each animal of discrete neuronal morphology (such as a nucleolus) using a microtome (D-6900 Heidelberg HM 400). Secin about 10 sections will provide a reliable estimate of tions were processed for free-floating immunohistototal cells within a specific population (33,71). Unfortuchemistry using antibodies against tyrosine hydroxylase nately, brain regions containing GDNF-transfected cells (TH) (1:500, Peel-Frez Inc.) and GDNF (1:250, R&D were narrow and would result in less than 4-5 sections Systems). Immunohistochemistry was performed acif samples were cut at a thickness of 50 µm or greater cording to our standard protocol (29). Controls included (thick sections are necessary for stereological analyses). sections where the primary antibody was omitted, as well
In addition, 6-OHDA-lesioned control brains contained as a preincubation with the appropriate antigen. The secless than 10 neurons per section (approximately 1-5 tions were washed in PBS, incubated with the secondary neurons) and this did not meet the criteria as established antibody, and reacted with the ABC solution (vectastain, by Gundersen (31) . [For further information regarding Vector Laboratories) and diaminobenzidine (DAB, Sigthe image analysis system used please see (6, 19, 21) .] ma) [0.0300 g/100 ml imidazole-acetate buffer solution (I-A) and 0.0500 g/100 ml I-A buffer solution with 2.5 RESULTS g nickel ammonium sulfate (NAS), Fisher Scientific].
Apomorphine-Induced Rotations The preincubation in DAB was carried out for 30 min with 3% hydrogen peroxide (H 2 O 2 ) before incubation Animals that received intranigral injections of rAAV-GDNF (n = 7) or the rAAV-GFP control (n = 8) exhib-in metal-intensified DAB solution. All sections were ited no gross behavioral changes following the injec-transfected cells in the substantia nigra on the lesioned side (n = 8; Fig. 3C, D) . However, animals that were tions. However, analysis of the apomorphine-induced rotational data showed a significant difference between injected with the rAAV-GDNF showed a significant but variable transfection, with GDNF-positive cells in the the two groups (Fig. 2 ). There was no mean decrease in rotations for animals injected with control virus. The area of the substantia nigra on the lesioned side (n = 7; Fig. 3A, B ). Four of these animals exhibited large clus-average rotation values for the controls pre-and postvirus were 470 ± 138 and 542 ± 88 turns, respectively.
ters of GDNF-positive neurons in this brain region. The highest number of GDNF-positive neurons estimated in By contrast, rats that received rAAV-GDNF showed a statistically significant decrease in apomorphine-induced a rAAV-GDNF-treated animal was 4795 (calculated from 4 sections that were separated by at least 200 µm). rotational behavior. The mean decrease in rotations was 49%, with some animals decreasing with as much as Most of these cell bodies were located in the pars compacta, with fibers extending into the pars reticulata and 95%. The average rotation values for the rAAV-GDNFinjected rats pre-and postvirus were 522 ± 111 and 267 ± the medial forebrain bundle. The animal that expressed the highest number of GDNF-immunoreactive cell bod-121 turns, respectively. An ANOVA with repeated measures demonstrated a significant difference between the ies also displayed the greatest reduction in apomorphineinduced rotations. two treatment groups following the virus injection (*p < 0.05) (Fig. 2) .
TH Immunohistochemistry GDNF Immunohistochemistry
TH immunohistochemistry demonstrated that animals injected with the control rAAV-GFP vector showed no Upon investigation of the brains from the rAAV-GFP controls under the fluorescence microscope, we found a or very few TH-immunoreactive cells in the substantia nigra on the lesioned side (n = 7; Fig. 4A , C, compared significant number of fluorescent neurons near the substantia nigra (Fig. 3C, inset) . However, no fluorescent with the unlesioned side, Fig. 4B ). When rAAV-GDNF was placed in the optimal location (in the substantia ni-labeling was observed in rAAV-GDNF-injected brains. GDNF immunohistochemistry revealed that animals in-gra proper; 4 cases), the percentage of TH-positive neurons relative to lesioned control values increased with a jected with the control rAAV-GFP showed no GDNF- mean value of 343%. (Optimal delivery was designated of TH-immunoreactive fibers in the medial forebrain bundle (Fig. 6 ). Animals that received control virus con-as injections placed directly into the substantia nigra proper. Those injections that were placed slightly out-tained very few, if any, TH-immunoreactive fibers in the medial forebrain bundle (Fig. 6B) , while the GDNF-side of the substantia nigra were designated as nonoptimal in terms of location. Both optimal-and nonoptimal-transfected animals exhibited a dense staining of neurites (Fig. 6D) . injected animals were evaluated in this study.) There was also a significant increase in the amount of TH-TH immunohistochemistry of the striatum ipsilateral to the injections of the control rAAV-GFP viral vector positive varicose fibers and bundles throughout the substantia nigra (Fig. 5A, C) . The distribution and morphol-did not reveal any labeling on the lesioned side, except for a few varicose fibers (Fig. 7B ). However, rAAV-ogy of TH-positive neurons on the lesioned side treated with rAAV-GDNF mimicked the distribution seen on GDNF injections produced an increase in TH-immunoreactive fibers, particularly in the ventro-medial region the intact side (Fig. 5B) in the same animal. The animal with the highest number of TH-positive neurons on the of the striatum (Fig. 7C ). This fiber upregulation in the target region was seen in five of the seven GDNF-trans-side ipsilateral to the lesion also contained a significant amount (1232) of GDNF-positive cells in the substantia fected animals. The pattern of innervation suggested that active collateral sprouting might occur, because growth nigra. Accordingly, a 79% reduction in apomorphineinduced rotations was observed in this animal. Upon cone-like features were observed in the parenchyma (Fig. 7C ). morphological evaluation of the tissue, no difference in cell size between "rescued" neurons on the lesioned side DISCUSSION or intact neurons on the unlesioned side was observed in any of the groups. In addition to the enhanced TH In these studies we used an animal model of PD to test the effects of rAAV-GDNF injection on damaged immunolabeling in the substantia nigra close to the injection site, we also observed a significant upregulation dopamine neurons. The rAAV-GDNF was administered once to the area dorsal to the substantia nigra 5 weeks treated animals. The behavioral and immunohistochemical results of this current study, however, support the following the neurotoxin-induced lesion. Apomorphineinduced rotational behavior was significantly decreased hypothesis that gene delivery of GDNF via injection of rAAV-GDNF into the substantia nigra of unilateral 6-in the rAAV-GDNF-treated rats compared with the rAAV-GFP control rats. This was associated with evi-OHDA-lesioned rats restores function to a significant proportion of the damaged dopamine neurons. dence of stable expression of GDNF. In fact, the two animals that displayed the greatest reduction in rotations
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In the present study, the effects of GDNF on damaged dopamine neurons using an rAAV-GDNF vector also contained the highest amount of GDNF immunoreactivity. It is interesting to note, however, that one of were similar to those observed with direct injections of GDNF (23, 24, 34) . The stable expression of GDNF pro-the rAAV-GDNF-treated animals displayed a low number of GDNF-positive neurons yet experienced a sub-duced by the viral vector caused a dramatic upregulation of TH-positive neurons in the substantia nigra of the uni-stantial reduction in rotational behavior. This warrants future studies, including the use of HPLC for a more lateral 6-OHDA-treated rats. Although the histological limitations precluded stereological analysis, these data quantitative analysis. There was also a dramatic increase in TH-positive cell bodies and dendrites in the substantia show that stable expression of GDNF produced a significant increase in cell number and TH-immunoreactive nigra and TH-positive fibers in the striatum and medial forebrain bundle of the rAAV-GDNF-treated animals.
dendrites. In addition to these effects in the substantia nigra, the sustained expression of GDNF was seen to Future studies stemming from this initial report will incorporate immunofluorescence histochemistry to determine produce effects on TH-positive fibers in the striatum and the medial forebrain bundle of the unilateral 6-OHDA-whether GDNF and TH are colocalized in rAAV-GDNF- treated rats. This is in contrast to the effects of direct ous studies from our laboratory, using fluorogold injections into the striatum (7) , have shown that a large por-GDNF injections in animals that have received 6-OHDA treatments analogous to this model (6, 29, 35) . Thus, the tion of the nigro-striatal dopamine neurons (50%) remain, albeit lacking TH immunostaining, several weeks fol-present studies support that chronic delivery of GDNF can upregulate the density of TH-positive fibers in target lowing a 6-OHDA lesion. In a recent study (73) , we investigated different forms of cell death versus pheno-regions of the dopamine neurons as well as in the nigra. This is clearly an improvement over the prior ap-typic loss in the substantia nigra short term following medial forebrain bundle injection of 6-OHDA. We proaches, which have been shown to predominately produce effects in the substantia nigra and adjacent areas found significant labeling with Fluorojade (a general cell death marker) as well as TUNEL (a more specific apop-and to have little effect on dopamine synthesis, storage, and release in the striatum. Thus, these data suggest that totic marker) in the medial substantia nigra pars compacta (A9) 12-48 h after 6-OHDA injections (73) . Interestingly, sustained administration of GDNF could lead to a more complete repair of the nigrostriatal pathway produced the lateral portion of A9 did not stain significantly for any of the cell death markers, even though a marked reduction by neurotoxins or in neurodegenerative diseases such as PD.
in TH was seen within 96 h of the neurotoxin injection.
These results correlate with the present findings in that It is not surprising that we found a partial restoration of striatal dopamine fibers with rAAV-GDNF injected the "rescued" TH-positive neurons were also located primarily in the lateral A9, while most medial neurons such a long time after the 6-OHDA lesion. In fact, previ- were absent. The findings also agree with our previous seen with single or repeated injections of GDNF directly into the substantia nigra of unilateral 6-OHDA-treated studies using fluorogold labeling (7) . Thus, medial A9 neurons may be more vulnerable to this particular type rats (6, 35) . It should be noted that, in the present study, behavioral studies were carried out 5 weeks postinjec-of neurotoxin exposure than the lateral portion of A9. It remains to be elucidated why the lateral neurons are able tion. Prior studies have demonstrated that maximal effects of GDNF are seen 2-4 weeks after a one-time in-to survive this severe injury better than the medial A9 neurons. It is possible that the biochemical composition jection of the protein. Thus, while the present effects are significant and indicative of a positive effect, future of neurons in different areas of A9 may make them more susceptible to cell death. For example, calbindin appears studies are needed to investigate long-term effects of rAAV-GDNF injections. Such data are needed to deter-to be expressed differently among neurons in the substantia nigra pars compacta of PD patients (17, 38) . Vari-mine if stable transfection of GDNF can be achieved over longer time periods. ations in calbindin content among neurons may impact the susceptibility of these cells to excitotoxic insults due For the present studies, we used a rAAV vector for GDNF in an attempt to rescue and restore function to to extreme elevations in intracellular calcium ions.
The rAAV-GDNF viral vector produced significant damaged and dying dopamine neurons. The advantages of rAAV vectors are that they have a very low associa-effects on apomorphine-induced rotational behavior. On average, animals that received the rAAV-GDNF exhib-tion with disease. They also have the ability to latently infect a large number of the cells in the area where the ited approximately 50% reductions in rotational behavior. In reality, some animals exhibited nearly a complete virus is injected, as well as the potential to infect nondividing cells and a broad range of cell types including cessation in rotational behavior as a consequence of viral delivery of GDNF. These effects are similar to those neurons (3). The rAAV vector also offers the potential to infect site-specific areas. rAAV has a few disadvan-a 6-OHDA lesion in the aged rat. It is possible that the delivery system and timeline of the different studies ex-tages as well, such as the low titer and the small area of insert. Mandel et al. (51) have shown that prior injection plain this regional difference in GDNF response, because previous studies have also reported GDNF effects of rAAV-GDNF vector can protect nigral dopamine neurons from degeneration in a rat model of PD. Our when given directly into the substantia nigra (6, 51) . These data, taken together with prior studies, support studies expand these earlier studies in that we examined rescue effects of the rAAV-GDNF given after the 6-that vector delivery of GDNF through an rAAV vector may provide a successful avenue towards a therapeutic OHDA treatment instead of neuroprotection before the lesion, a paradigm more relevant to human PD. There treatment strategy for PD. In the present study, an rAAV-GDNF vector produced stable transfection of GDNF in have also been studies where rAAV has been used with tyrosine hydroxylase and aromatic L-amino acid decar-the substantia nigra of the unilateral 6-OHDA-treated rat for at least 4 weeks. Unlike prior studies with GDNF boxylase (22) . Based on these advantages of rAAV vectors, they could prove to be a safe vector for human protein, the rAAV-GDNF produced an increase in THpositive fibers in the medial forebrain bundle and the clinical trials and efficient because they offer a longterm stable transfection. striatum ipsilateral to the viral injection. These findings hold promise as a potential treatment paradigm for pa-The AAV vectors are closely related to adenoviruses (Ad). However, adenoviruses can trigger a strong in-tients with PD. flammatory reaction that can lead to the destruction of ACKNOWLEDGMENTS: This work was supported by USPHS the infected cells (2) . Because of this property, its clinigrants AG06434, AG13494, and NS39787, as well as U.S. army grant DAMD17-99-1-9480. Drs. Granholm and Gercal applications could be limited. Despite the fact that hardt were supported by Research Scientist Development Ad vectors are inflammatory to a higher degree than Awards (AG00796 and MH01245, respectively). This work AAV, successful treatment with Ad-GDNF has been de- to what we report in the present study. Connor et al. (16) have been able to show that Ad-GDNF vectors can protect dopaminergic neurons in the substantia nigra of REFERENCES young rats and have found that increased levels of stria- 
